$14.8 M

BPTH Mkt cap, 23-Sept-2020
Bio-Path Holdings Net income (Q2, 2020)-2 M
Bio-Path Holdings EBIT (Q2, 2020)-2 M
Bio-Path Holdings Cash, 30-Jun-202014.4 M
Bio-Path Holdings EV729.4 K

Bio-Path Holdings Income Statement

Annual

USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Revenue

13.0k37.0k

R&D expense

1.5m1.6m3.0m5.5m5.5m4.6m4.6m

General and administrative expense

1.2m986.1k1.6m2.7m2.5m3.0m3.5m3.4m4.1m

Operating expense total

1.2m986.1k3.2m4.3m5.5m8.5m9.0m8.0m8.7m

Depreciation and amortization

10.3k

EBIT

(2.4m)(2.6m)(3.3m)(4.5m)(5.5m)(8.5m)(9.0m)(8.6m)(8.7m)

EBIT margin, %

(65192%)(24232%)

Interest expense

2.3k1.7m1.9m7.0k

Interest income

2.9k779.04.0k22.6k17.7k12.0k9.0k7.0k94.0k

Pre tax profit

(2.4m)(2.6m)(3.3m)(4.5m)(5.5m)(6.7m)(7.0m)(8.6m)(8.6m)

Income tax expense

Net Income

(2.4m)(2.6m)(3.3m)(4.5m)(5.5m)(6.7m)(7.0m)(8.6m)(8.6m)

Bio-Path Holdings Balance Sheet

Annual

USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Cash

952.3k534.0k3.6m13.9m8.9m9.4m6.0m1.0m20.4m

Accounts Receivable

Prepaid Expenses

48.4k42.6k64.1k100.5k179.0k1.1m332.0k776.0k

Inventories

Current Assets

1.2m771.6k3.7m14.1m9.6m10.7m7.4m1.9m22.0m

PP&E

113.1k72.0k614.0k654.0k406.0k303.0k

Total Assets

3.2m2.3m5.1m15.5m10.8m12.2m8.9m2.3m22.7m

Accounts Payable

121.5k57.0k76.1k41.0k54.6k69.0k52.0k813.0k486.0k

Short-term debt

791.5k928.2k85.0k

Current Liabilities

316.1k329.2k294.9k562.0k937.4k1.1m791.0k1.1m1.2m

Long-term debt

330.0k

Total Debt

791.5k1.7m415.0k

Total Liabilities

316.1k329.2k294.9k562.0k937.4k4.0m791.0k1.1m1.6m

Common Stock

58.3k62.2k84.2k89.8k89.8k11.0k1.0k4.0k

Preferred Stock

Additional Paid-in Capital

12.4m13.3m20.1m34.7m35.1m40.3m47.2m49.0m77.4m

Retained Earnings

(25.4m)(32.1m)(39.2m)(47.7m)(56.3m)

Total Equity

2.9m2.0m4.8m14.9m9.8m8.2m8.1m1.2m21.1m

Debt to Equity Ratio

0.3 x0.2 x

Debt to Assets Ratio

0.2 x0.2 x

Financial Leverage

1.1 x1.2 x1.1 x1 x1.1 x1.5 x1.1 x1.9 x1.1 x

Quarterly

USDQ2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020

Cash

1.2m983.3k576.8k162.4k332.9k288.7k1.9m4.1m16.8m15.7m14.6m12.5m11.1m9.9m6.5m4.2m11.3m7.1m6.2m4.6m4.3m2.6m2.3m19.3m17.1m15.4m17.9m14.4m

Prepaid Expenses

45.1k52.0k56.3k46.5k45.4k53.9k46.4k49.7k157.5k171.6k194.2k122.6k253.6k200.8k750.0k1.3m196.0k377.0k592.0k653.0k1.3m1.3m257.0k427.0k654.0k765.0k764.0k1.1m

Current Assets

1.3m1.0m654.2k504.4k457.8k438.6k2.3m4.3m17.2m16.0m14.9m12.9m12.0m10.5m7.8m6.1m12.4m8.4m7.8m5.8m5.9m4.5m2.8m20.9m18.6m16.9m19.2m16.9m

PP&E

102.8k92.6k82.3k62.0k51.0k66.0k872.0k797.0k720.0k605.0k539.0k473.0k340.0k307.0k321.0k285.0k267.0k

Total Assets

3.7m3.4m2.7m2.2m2.1m2.0m3.7m5.8m18.6m17.4m16.3m14.2m13.3m11.7m8.9m7.1m13.4m10.1m9.4m7.3m7.2m5.7m3.9m21.3m19.3m17.6m19.8m17.5m

Accounts Payable

24.2k43.1k58.4k31.1k65.4k71.9k165.9k43.6k238.0k78.9k88.5k76.6k385.1k127.1k201.0k123.0k118.0k89.0k96.0k121.0k136.0k137.0k451.0k607.0k444.0k522.0k818.0k726.0k

Short-term debt

684.2k737.2k839.6k839.6k(888.1k)968.4k1.0m87.0k89.0k

Current Liabilities

220.7k205.0k246.6k243.0k268.6k290.4k267.9k173.8k420.0k333.5k283.2k616.2k692.2k481.2k900.0k813.0k866.0k709.0k576.0k767.0k929.0k1.0m957.0k1.1m1.0m1.2m1.6m1.2m

Long-term debt

59.0k373.0k352.0k307.0k284.0k

Total Debt

684.2k737.2k839.6k839.6k(888.1k)1.5m1.5m1.5m1.6m1.7m1.7m1.8m1.8m1.9m59.0k373.0k352.0k394.0k373.0k

Total Liabilities

220.7k205.0k246.6k243.0k268.6k290.4k267.9k173.8k420.0k333.5k283.2k616.2k692.2k481.2k900.0k813.0k4.1m2.0m576.0k767.0k929.0k1.0m957.0k1.2m1.4m1.6m1.9m1.5m

Common Stock

56.1k56.1k58.5k58.9k58.9k62.2k75.4k75.4k89.2k89.2k89.2k89.8k89.8k89.8k90.0k90.0k96.0k96.0k100.0k100.0k11.0k11.0k13.0k3.0k3.0k3.0k4.0k4.0k

Preferred Stock

Additional Paid-in Capital

11.6m11.7m12.5m12.6m12.5m13.3m16.6m16.9m34.0m34.1m34.2m34.8m34.9m35.0m35.2m35.4m40.0m40.5m43.3m43.4m47.3m47.5m48.8m69.4m69.6m70.0m77.6m77.7m

Retained Earnings

(22.4m)(23.9m)(27.3m)(29.2m)(30.8m)(32.5m)(34.5m)(37.0m)(41.1m)(42.7m)(45.8m)(49.3m)(51.7m)(53.9m)(59.7m)(61.7m)

Total Equity

3.4m3.2m2.5m1.9m1.8m1.7m3.5m5.6m18.2m17.0m16.0m13.6m12.6m11.2m8.0m6.3m9.4m8.1m8.9m6.5m6.3m4.7m3.0m20.1m17.9m16.0m17.9m16.0m

Debt to Equity Ratio

0.2 x0.2 x0.3 x0.4 x-0.5 x0.2 x0.2 x0.2 x0.2 x0.2 x0.3 x0.3 x0.4 x0.6 x0 x0 x

Debt to Assets Ratio

0.2 x0.2 x0.3 x0.4 x-0.4 x0.2 x0.2 x0.1 x0.2 x0.2 x0.2 x0.2 x0.3 x0.5 x0 x0 x

Financial Leverage

1.1 x1.1 x1.1 x1.1 x1.1 x1.2 x1.1 x1 x1 x1 x1 x1 x1.1 x1 x1.1 x1.1 x1.4 x1.2 x1.1 x1.1 x1.1 x1.2 x1.3 x1.1 x1.1 x1.1 x1.1 x1.1 x

Bio-Path Holdings Cash Flow

Annual

USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Net Income

(2.4m)(2.6m)(3.3m)(4.5m)(5.5m)(6.7m)(7.0m)(8.6m)(8.6m)

Depreciation and Amortization

211.7k928.2k160.6k170.9k201.8k204.0k411.0k426.0k134.0k

Accounts Receivable

244.5k

Inventories

(64.6k)42.0k143.6k(103.3k)(404.8k)

Accounts Payable

69.4k13.1k(34.3k)267.1k375.4k(146.0k)326.0k(168.0k)

Cash From Operating Activities

(1.1m)(2.0m)(2.3m)(3.8m)(5.0m)(8.1m)(8.0m)(6.1m)(8.4m)

Purchases of PP&E

(123.4k)(338.0k)(538.0k)(17.0k)

Cash From Investing Activities

(170.1k)(25.0k)(123.4k)(338.0k)(538.0k)(17.0k)

Cash From Financing Activities

2.0m1.6m5.3m14.2m9.0m5.1m1.2m27.8m

Net Change in Cash

713.7k(418.2k)3.0m10.3m(5.0m)521.0k(3.4m)(5.0m)19.4m

Interest Paid

Income Taxes Paid

Quarterly

USDQ2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020

Net Income

(1.1m)(1.6m)(522.2k)(1.3m)(2.2m)(656.0k)(1.1m)(2.5m)(504.9k)(1.8m)(2.9m)(1.4m)(2.5m)(4.0m)(1.9m)(3.8m)(5.4m)(397.0k)(2.4m)(4.9m)(1.9m)(3.6m)(6.7m)(1.5m)(4.0m)(6.2m)(3.3m)(5.4m)

Depreciation and Amortization

104.5k157.5k48.1k96.6k145.1k40.2k80.3k120.5k40.2k80.3k120.5k50.4k100.9k151.3k50.0k101.0k152.0k73.0k188.0k305.0k106.0k212.0k319.0k66.0k99.0k116.0k18.0k36.0k

Accounts Receivable

244.5k244.5k

Inventories

88.4k88.4k132.0k(142.5k)73.5k(99.0k)(84.2k)46.7k(197.7k)(90.0k)(45.2k)(204.2k)(541.2k)(249.7k)(51.0k)(19.0k)

Accounts Payable

(26.0k)(41.8k)(69.5k)(73.1k)(47.6k)(38.8k)(61.4k)(155.5k)125.1k38.6k(11.7k)54.3k130.2k(80.7k)(37.0k)(124.0k)(71.0k)(208.0k)(257.0k)(36.0k)138.0k214.0k166.0k(54.0k)(328.0k)(187.0k)341.0k(23.0k)

Cash From Operating Activities

(375.6k)(726.2k)(400.2k)(1.0m)(1.6m)(551.0k)(1.1m)(1.8m)(544.4k)(1.6m)(2.7m)(1.4m)(2.8m)(4.0m)(2.4m)(4.6m)(6.5m)(1.8m)(4.2m)(5.7m)(1.7m)(3.4m)(4.8m)(2.0m)(4.2m)(6.1m)(2.5m)(6.0m)

Purchases of PP&E

(66.1k)(25.0k)(424.0k)(538.0k)(538.0k)(17.0k)(17.0k)(17.0k)

Cash From Investing Activities

(37.5k)(62.5k)(25.0k)(25.0k)(25.0k)(66.1k)(25.0k)(424.0k)(538.0k)(538.0k)(17.0k)(17.0k)(17.0k)

Cash From Financing Activities

1.4m1.5m49.8k264.7k973.1k305.7k2.5m5.4m13.8m13.8m13.8m9.0m1.5m1.5m1.2m20.3m20.3m20.5m

Net Change in Cash

983.1k744.7k(375.4k)(789.8k)(619.4k)(245.3k)1.4m3.6m13.3m12.2m11.1m(1.4m)(2.8m)(4.0m)(2.4m)(4.6m)2.4m(2.3m)(3.2m)(4.8m)(1.7m)(3.4m)(3.7m)18.3m16.1m14.4m(2.5m)(6.0m)

Interest Paid

Income Taxes Paid

Bio-Path Holdings Ratios

USDQ2, 2011

Debt/Equity

0.2 x

Debt/Assets

0.2 x

Financial Leverage

1.1 x